NOVARTIS AG (NVS)

NYSE · Pharmaceutical Preparations · Inc. V8

What they're doing

Between 2026-08-02 and 2026-10-31, public records show 17 signals for NOVARTIS AG. Most notable: 2026-10-03: Federal obligations of $14.2M in 30 days, 3.7x the prior-year pace; 2026-10-06: Federal obligations of $14.2M in 30 days, 3.7x the prior-year pace; 2026-10-07: Federal obligations of $14.2M in 30 days, 3.7x the prior-year pace. Federal contract obligations over the last 24 months total $45,879,504. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-10-31 from public records.

Signals, last 12 months

  1. Surge in federal contracts
    Federal obligations of $11.9M in 30 days, 3.0x the prior-year pace
  2. Surge in federal contracts
    Federal obligations of $11.9M in 30 days, 3.0x the prior-year pace
  3. Surge in federal contracts
    Federal obligations of $12.1M in 30 days, 3.1x the prior-year pace
  4. Surge in federal contracts
    Federal obligations of $12.1M in 30 days, 3.1x the prior-year pace
  5. Surge in federal contracts
    Federal obligations of $13.1M in 30 days, 3.4x the prior-year pace
  6. Surge in federal contracts
    Federal obligations of $13.1M in 30 days, 3.4x the prior-year pace
  7. Surge in federal contracts
    Federal obligations of $13.1M in 30 days, 3.4x the prior-year pace
  8. Surge in federal contracts
    Federal obligations of $13.1M in 30 days, 3.4x the prior-year pace
  9. Surge in federal contracts
    Federal obligations of $13.1M in 30 days, 3.4x the prior-year pace
  10. Surge in federal contracts
    Federal obligations of $13.7M in 30 days, 3.6x the prior-year pace
  11. Surge in federal contracts
    Federal obligations of $14.2M in 30 days, 3.8x the prior-year pace
  12. Surge in federal contracts
    Federal obligations of $14.2M in 30 days, 3.8x the prior-year pace
  13. Surge in federal contracts
    Federal obligations of $14.2M in 30 days, 3.8x the prior-year pace
  14. Surge in federal contracts
    Federal obligations of $14.2M in 30 days, 3.8x the prior-year pace
  15. Surge in federal contracts
    Federal obligations of $14.2M in 30 days, 3.7x the prior-year pace
  16. Surge in federal contracts
    Federal obligations of $14.2M in 30 days, 3.7x the prior-year pace
  17. Surge in federal contracts
    Federal obligations of $14.2M in 30 days, 3.7x the prior-year pace

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2020-07-14NOVARTIS PHARMA AG; NOVARTIS AGten percent ownerC5,908,089——
2020-06-30Novartis Bioventures Ltd; NOVARTIS AGotherC856,262——
2020-06-30Novartis Bioventures Ltd; NOVARTIS AGotherC199,996——
2020-06-30Novartis Bioventures Ltd; NOVARTIS AGotherP125,00017$2,125,000
2020-06-19Novartis Bioventures Ltd; NOVARTIS AGotherS1,001,3128.25$8,260,824
2020-06-18Novartis Bioventures Ltd; NOVARTIS AGotherS9009.04$8,136
2020-06-17Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS4,6229.27$42,846
2020-06-16Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS8,6009.3$79,980
2020-06-15Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS6,1649.05$55,784
2020-06-12Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS1,5009.19$13,785
2020-06-11Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS7,2009.21$66,312
2020-06-10Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS8,5329.46$80,713
2020-06-09Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS7,0009.38$65,660
2020-06-08Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS5,6599.66$54,666
2020-06-05Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS8,6529.66$83,578
2020-06-04Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS4,0889.55$39,040
2020-06-03Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS5,2089.78$50,934
2020-06-02Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS5,6699.68$54,876
2019-11-12Novartis Bioventures Ltd; NOVARTIS AGten percent ownerC3,293,067——
2019-11-12Novartis Bioventures Ltd; NOVARTIS AGten percent ownerP250,00012$3,000,000
2019-05-28Novartis Bioventures Ltd; NOVARTIS AGten percent ownerC893,195——
2019-05-28Novartis Bioventures Ltd; NOVARTIS AGten percent ownerX71,450——
2019-05-28Novartis Bioventures Ltd; NOVARTIS AGten percent ownerC636,366——
2019-05-28Novartis Bioventures Ltd; NOVARTIS AGten percent ownerP168,63014$2,360,820
2019-04-26Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS138,7041.03$142,865
2019-04-25Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS563,0961.03$579,989
2019-04-24Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS16,4031.03$16,895
2019-04-23Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS27,5541.03$28,381
2019-04-22Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS7,1000.97$6,887
2019-04-15Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS28,7940.99$28,506
2019-04-12Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS30,9081.04$32,144
2019-04-11Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS57,4381.08$62,033
2019-04-10Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS140,2301.09$152,851
2019-04-09Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS32,9911.01$33,321
2019-04-08Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS27,5251.02$28,076
2019-04-05Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS24,6611.02$25,154
2019-04-04Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS47,9001.01$48,379
2019-04-03Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS58,0330.96$55,712
2019-04-02Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS51,7540.97$50,201
2019-04-01Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS20,6101.9$39,159
2019-04-01Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS116,9090.95$111,064
2019-03-29Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS106,5401.85$197,099
2019-03-29Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS63,1000.91$57,421
2019-03-28Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS88,8350.94$83,505
2019-03-27Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS50,7490.99$50,242
2019-03-26Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS177,7621.01$179,540
2019-03-15Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS43,8001.92$84,096
2019-03-14Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS13,8001.88$25,944
2019-03-13Novartis Bioventures Ltd; NOVARTIS AGten percent ownerS132,7382.12$281,405
2018-09-12Novartis Bioventures Ltd; NOVARTIS AGten percent ownerJ2,069,993——

Federal contracts

24-month federal obligations: $42,899,686

2024-11: $1,702,0462024-12: $5,543,5572025-01: $-384,6912025-02: $4,565,7312025-03: $-1,952,3332025-04: $-2,213,4242025-05: $-995,9212025-06: $-2,190,3392025-07: $-1,626,5792025-08: $518,7882025-09: $735,4922025-10: $7,809,8702025-11: $-206,4492025-12: $10,850,0432026-01: $2,017,7842026-02: $12,217,8142026-03: $-998,3642026-04: $-1,119,6092026-05: $360,0102026-06: $-1,008,3102026-07: $-2,049,7032026-08: $-303,9012026-09: $1,890,9722026-10: $9,737,201
  • 2026-02-24 $4,732,608 · Department of Veterans Affairs · PLUVICTO
  • 2026-02-06 $4,162,659 · Department of Veterans Affairs · LU177 - PLUVICTO/LUTATHERA
  • 2026-10-01 $4,115,311 · Department of Veterans Affairs · PLUVICTO NDC: 69488-0010-61
  • 2025-02-07 $4,106,392 · Department of Veterans Affairs · LUTATHERA & PLUVICTO
  • 2025-10-01 $3,987,497 · Department of Veterans Affairs · PLUVICTO DRUG
  • 2025-10-08 $3,914,028 · Department of Veterans Affairs · PLUVICTO AND LUTATHERA
  • 2024-11-22 $3,363,558 · Department of Defense · FY25 FUNDING MODIFICATION FOR LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
  • 2025-12-08 $3,175,976 · Department of Defense · LUTATHERA AND PLUVICTO - FY26 FUNDING FOR CLINS 0001 AND 0002 FOR POP DATE FROM 1OCT25 TO 30 SEPT 26.
  • 2026-09-30 $2,537,775 · Department of Veterans Affairs · PLUVICTO
  • 2026-02-09 $2,423,133 · Department of Veterans Affairs · RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

7-day average 445 views/day vs 90-day median 455.

Recent filings